Overview

Price chart · mood · technical indicators

AMGN

Amgen Incstock Healthcare

Drug Manufacturers - General

$323.8519.75%Current Market Mood:Neutral

Market Mood

Price Range (1Y)

$261.43$391.29

Current: $323.85

Idea: EMA

1Y Return

+11.4%

Sharpe 3Y

0.58

Market Comparison

vs Healthcare Sector & Drug Manufacturers - General Industry

AMGN

+19.75%

1Y Performance

Healthcare

Sector 1Y

Drug Manufacturers - General

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio22.94Forward 14.75

EPS (TTM)$14.384.4% YoY

Profit margin21.0%HEALTHCARE

Market cap$178.00BLarge cap

Wall Street coverage

$353.43median target· current $299.48 (+18.0%)35 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 14.75
PEG ratio: 2.17
P/B: 19.37
P/S (TTM): 4.78
EV/EBITDA: 13.40

Profitability & growth

ROE (TTM): 101.3%
Operating margin: 33.8%
Revenue growth YoY: 5.8%
Dividend yield: 2.8%
Beta: 0.47

Last earnings

Apr 29, 2026 · Estimate $5.16 · Reported $5.15

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Amgen Inc

Company profile

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

Classification

Sector: Healthcare
Industry: Drug Manufacturers - General
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Fiscal year end: December
Latest quarter: Mar 31, 2026

Market cap$178.00B

Shares outstanding$539.7M

52W high$391.29

52W low$253.48

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

AMGN

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis

[144] AMGEN INC SEC Filing

Dominion Energy Stock Posts Strong Q1 With Budget Cut and Turbine Cadence Accelerating

Chevron Q1 2026 Earnings: Adjusted EPS Beats by 46%, But Margin Pressure Persists

Amgen to Invest $300 Million in Expanding Puerto Rico Biologics Plant

Amgen to invest additional $300 million to boost US manufacturing footprint

Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger

Amgen announces additional $300 million U.S. manufacturing investment, totaling nearly $2 billion over the last year

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

Guggenheim cuts Amgen stock price target to $340 on valuation

TWIST BIOSCIENCE ($TWST) Releases Q2 2026 Earnings

Baron Health Care Fund’s Performance Impacted by Amgen (AMGN) Omission

Truist Financial Corp Sells 37,080 Shares of Amgen Inc. $AMGN

Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?

Gouws Capital LLC Lowers Stock Position in Amgen Inc. $AMGN

Amgen Sees C-Suite Shifts

Amgen Inc. $AMGN Shares Purchased by Ascent Wealth Partners LLC

How Investors Are Reacting To Biogen (BIIB) Earnings Beat, Lower Guidance, And Felzartamab China Deal

Amgen Inc. $AMGN Shares Sold by PKO Investment Management Joint Stock Co

Hussman Strategic Advisors Inc. Acquires Shares of 8,400 Amgen Inc. $AMGN

About Amgen Inc

Classification

Company profile

AMGN

Market Comparison

AMGN Market Analysis

Overview

AMGN

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis

[144] AMGEN INC SEC Filing

Dominion Energy Stock Posts Strong Q1 With Budget Cut and Turbine Cadence Accelerating

Chevron Q1 2026 Earnings: Adjusted EPS Beats by 46%, But Margin Pressure Persists

Amgen to Invest $300 Million in Expanding Puerto Rico Biologics Plant

Amgen to invest additional $300 million to boost US manufacturing footprint

Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger

Amgen announces additional $300 million U.S. manufacturing investment, totaling nearly $2 billion over the last year

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

Guggenheim cuts Amgen stock price target to $340 on valuation

TWIST BIOSCIENCE ($TWST) Releases Q2 2026 Earnings

Baron Health Care Fund’s Performance Impacted by Amgen (AMGN) Omission

Truist Financial Corp Sells 37,080 Shares of Amgen Inc. $AMGN

Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?

Gouws Capital LLC Lowers Stock Position in Amgen Inc. $AMGN

Amgen Sees C-Suite Shifts

Amgen Inc. $AMGN Shares Purchased by Ascent Wealth Partners LLC

How Investors Are Reacting To Biogen (BIIB) Earnings Beat, Lower Guidance, And Felzartamab China Deal

Amgen Inc. $AMGN Shares Sold by PKO Investment Management Joint Stock Co

Hussman Strategic Advisors Inc. Acquires Shares of 8,400 Amgen Inc. $AMGN

About Amgen Inc

Classification

Company profile

AMGN

Market Comparison